Psychedelic Legislation in New Jersey
Psychedelic therapy is not yet legal in New Jersey, but there is active legislation that could change that — nothing is in effect yet.
Psychedelic therapy is not yet legal in New Jersey, but there is active legislation working its way through the state legislature.
This page covers the current legal status of psychedelics in New Jersey, pending bills that could change that status, and how New Jersey compares to the national landscape. The psychedelic policy space is moving fast — here's where New Jersey stands.
Getting treatment in New Jersey
Whether psychedelic therapy is available here — and where to find it.
Legal Status by Substance
A-5464 introduced for medical framework.
Where to access therapy
Supervised psychedelic therapy isn’t available to the public in New Jersey yet. It is operating today in Oregon and Colorado, and New Mexico’s medical program is launching.
For providers: getting licensed & preparing for legalization
New Jersey enacted a psilocybin therapy pilot in January 2026 (S2283), funding trials at three hospitals — this is a $6M research-oriented pilot, not open public access.
New Jersey has enacted or advanced a program or pilot, but access isn't live yet. If you're a clinician here, the work now is positioning — understanding the emerging rules and building the credentials that will transfer when the program stands up.
What to do now
The Psilocybin Behavioral Health Access and Therapy Pilot runs through three hospitals (North, Central, and South Jersey) and is overseen by an 11-member advisory board.
- The near-term work is happening inside the three participating hospital systems — position for research and trial-support roles there.
- The most concrete step available today, in any state, is ketamine-assisted psychotherapy — the one legal, broadly available psychedelic-adjacent modality clinicians can train in and practice right now. It builds the exact skills (set and setting, preparation, dosing-session support, integration) that psilocybin and MDMA programs will require.
In August 2026, SAMHSA — the federal Substance Abuse and Mental Health Services Administration — published a report urging states to begin planning for the legal, operational, and Medicaid implications of potential FDA-approved psychedelic therapies, including credentialing, safety protocols, and consent standards. Across recent federal activity, the supply of trained clinicians is consistently named as the main bottleneck to access — which is exactly what preparing early addresses.
Source: SAMHSA (2026) — Current Research, Regulatory, and Policy Considerations: Psychedelics Medicine (PEP26-01-004)Sources: McCarter & English (2026)
Frequently asked questions
Is psilocybin therapy legal in New Jersey?
Psychedelic therapy is not yet legal in New Jersey, but there is active legislation that could change that — nothing is in effect yet.
When will psychedelic therapy be legal in New Jersey?
There is no guaranteed date — timelines depend on the legislature and, where a law has passed, on the rulemaking process. This page tracks New Jersey's current status; watch the legislation and advisory-board updates for the clearest signal.
Can I prepare to become a psychedelic therapist in New Jersey before it's legal?
Yes. You can begin training in psychedelic-assisted therapy now, build transferable clinical skills, and follow New Jersey's policy process so you're ready when a program opens. The provider section on this page outlines concrete steps.